Cited by 81Metabolism, Diabetes, and CancerPeroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity

Open access
Liang, Huiyun, Balas, Bogdan, Tantiwong, Puntip, Dube, John, Goodpaster, Bret H., O'Doherty, Robert M., DeFronzo, Ralph A., Richardson, Arlan +2 more·2009·American Journal of Physiology-Endocrinology and Metabolism

Abstract

Type 2 diabetes is characterized by fasting hyperglycemia, secondary to hepatic insulin resistance and increased glucose production. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) is a transcriptional coactivator that is thought to control adaptive responses to physiological stimuli. In liver, PGC-1alpha expression is induced by fasting, and this effect promotes gluconeogenesis. To examine whether PGC-1alpha is involved in the pathogenesis of hepatic insulin resistance, we generated transgenic (TG) mice with whole body overexpression of human PGC-1alpha and evaluated glucose homeostasis with a euglycemic-hyperinsulinemic clamp. PGC-1alpha was moderately (approximately 2-fold) overexpressed in liver, skeletal muscle, brain, and heart of TG mice. In liver, PGC-1alpha overexpression resulted in increased expression of hepatocyte nuclear factor-4alpha and the gluconeogenic enzymes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase. PGC-1alpha overexpression caused hepatic insulin resistance, manifested by higher glucose production and diminished insulin suppression of gluconeogenesis. Paradoxically, PGC-1alpha overexpression improved muscle insulin sensitivity, as evidenced by elevated insulin-stimulated Akt phosphorylation and peripheral glucose disposal. Content of myoglobin and troponin I slow protein was increased in muscle of TG mice, indicating fiber-type switching. PGC-1alpha overexpression also led to lower reactive oxygen species production by mitochondria and reduced IKK/IkappaB signaling in muscle. Feeding a high-fat diet to TG mice eliminated the increased muscle insulin sensitivity. The dichotomous effect of PGC-1alpha overexpression in liver and muscle suggests that PGC-1alpha is a fuel gauge that couples energy demands (muscle) with the corresponding fuel supply (liver). Thus, under conditions of physiological stress (i.e., prolonged fast and exercise training), increased hepatic glucose production may help sustain glucose utilization in peripheral tissues.

Integrity signals

Registry

Crossref · 10.1152/ajpendo.90292.2008

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These same animals displayed increased liver gluconeogenic enzyme levels and impaired insulin suppression of hepatic glucose production, thus nullifying the potentially beneficial effect of modest muscle PGC-1α overexpression on whole-body glucose homeostasis.

    “However, these same animals displayed increased liver gluconeogenic enzyme levels and impaired insulin suppression of hepatic glucose production, thus nullifying the potentially beneficial effect of modest muscle PGC-1␣ overexpression on whole-body glucose homeostasis.”
  • This modest PGC-1α overexpression was accompanied by decreased levels of ROS and inflammatory signaling.

    “Importantly, this modest PGC-1␣ overexpression also was accompanied by decreased levels of ROS and inflammatory signaling.”
  • Transgenic mice expressing human PGC-1α driven by its own promoter displayed a modest (30% higher than basal) increase in mRNA expression of several OXPHOS genes, fiber type switching, and enhanced muscle insulin sensitivity.

    “Similarly, transgenic mice expressing human PGC-1␣ driven by its own promoter displayed a modest (30% higher than basal) increase in mRNA expression of several OXPHOS genes, fiber type switching, and enhanced muscle insulin sensitivity (262).”
  • Modest overexpression of PGC-1α and transgenic overexpression of PGC-1β increase oxidative metabolism and insulin sensitivity.

    “Taken together, these studies suggest that modest overexpression of PGC-1␣ (261, 262) and transgenic overexpression of PGC-1␤ (271, 272) increase oxidative metabolism and insulin sensitivity.”
  • Whole-body PGC-1α transgenic expression driven by its own promoter increased mitochondrial DNA by 200-300% (Ward, 2009).

    “1 200 -300%”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Liang, H., Balas, B., Tantiwong, P., Dube, J., Goodpaster, B. H., O'Doherty, R. M., DeFronzo, R. A., Richardson, A., Musi, N., & Ward, W. F.
Affiliations
  • The University of Texas at San Antonio Health Science Center (US)
  • University of Pittsburgh (US)
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2009-04
Volume
296
Issue
4
Pages
E945-E954
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2134307023
Cited by
81
References
50
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 1 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 11 · 2013: 6 · 2012: 6
FWCI
2.96
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • National Institute on Aging (1P30- AG13319, R37AG026557, AG013319, AG-26557, AG-028294, P30AG013319)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-058855, R01DK080157, DK 24092, R01DK058855, DK-080157)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
PGC-1α, hepatic insulin resistance, skeletal muscle insulin sensitivity, type 2 diabetes, gluconeogenesis, glucose production, HNF4α, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, Akt phosphorylation, muscle fiber type shift, reactive oxygen species, NF-κB signaling, high-fat diet, fasting, glucose homeostasis, transgenic mice
MeSH terms
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Feeding Behavior, Female, Gluconeogenesis, Heat-Shock Proteins, Humans, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Inbred DBA, Mice, Transgenic, Transcription Factors, Up-Regulation, Reactive Oxygen Species, Muscle, Skeletal, Genes, Mitochondrial, Lipid Metabolism, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review